CRISPR and Cancer

Cancer Trials
Indicator
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
Castration-Resistant Prostate Cancer, (NCT06895811)
Sponsors:
Shanghai Changzheng Hospital
Indicator
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Relapsed/​Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoma, (NCT06934382)
Sponsors:
Stephan Grupp MD PhD, Children's Hospital of Philadelphia
Indicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine